Author:
Nikbin Vajihe Sadat,Gholizadeh Khiavi Elham Haj Agha,Dehghani-Latani Mehdi,Hosseinzadeh Majid,Shirzadi Mohammad,Pourajam Samaneh,Nouri Samereh,Solgi Hamid
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Gu J, Xu J, Zuo TT, Chen YB (2021) Ceftazidime-Avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae: ceftazidime-avibactam against CR-KP infections. J Glob Antimicrob Resist 26:20–25
2. Tumbarello M, Raffaelli F, Giannella M, Mantengoli E, Mularoni A, Venditti M et al (2021) Ceftazidime-Avibactam Use for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infections: a Retrospective Observational Multicenter Study. Clin Infect Dis 73(9):1664–1676
3. Karaiskos I, Daikos GL, Gkoufa A, Adamis G, Stefos A, Symbardi S et al (2021) Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study. J Antimicrob Chemother 76(3):775–783
4. Errico G, Del Grosso M, Pagnotta M, Marra M, Carollo M, Cerquetti M et al (2023) Whole-genome sequencing and molecular analysis of Ceftazidime-Avibactam-resistant KPC-Producing Klebsiella pneumoniae from intestinal colonization in Elderly patients. Antibiot (Basel). ;12(8)
5. Ghanbarinasab F, Haeili M, Ghanati SN, Moghimi M (2023) High prevalence of OXA-48-like and NDM carbapenemases among carbapenem resistant Klebsiella pneumoniae of clinical origin from Iran. Iran J Microbiol 15(5):609–615